Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
01 1Wavelength Enterprises LTD
02 1COHANCE LIFESCIENCES LIMITED
03 1B&B Pharmaceuticals, Inc.
04 1Cambrex Profarmaco Milano Srl
05 1F.I.S. FABBRICA ITALIANA SINTETICI S.P.A.
06 1Fagron Inc
07 1Formil Quimica Ltda
08 1LETCO MEDICAL, LLC
09 1Pharma Source Direct, Inc.
10 1Professional Compounding Centers of America dba PCCA
11 1Spectrum Laboratory Products, Inc.
01 2MIDAZOLAM
02 8Midazolam
03 1midazolam base
01 1Brazil
02 1France
03 1India
04 1Italy
05 1Netherlands
06 5U.S.A
07 1United Kingdom
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
NDC Package Code : 58175-0350
Start Marketing Date : 2001-02-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 17511-115
Start Marketing Date : 2020-01-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63275-9925
Start Marketing Date : 2017-01-01
End Marketing Date : 2025-08-01
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 12828-0069
Start Marketing Date : 1996-10-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0098
Start Marketing Date : 2011-05-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-1023
Start Marketing Date : 2020-07-22
End Marketing Date : 2026-11-30
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 79037-001
Start Marketing Date : 2020-06-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-3094
Start Marketing Date : 2024-02-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0001
Start Marketing Date : 2015-05-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-4721
Start Marketing Date : 2000-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Midazolam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Midazolam, including repackagers and relabelers. The FDA regulates Midazolam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Midazolam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Midazolam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Midazolam supplier is an individual or a company that provides Midazolam active pharmaceutical ingredient (API) or Midazolam finished formulations upon request. The Midazolam suppliers may include Midazolam API manufacturers, exporters, distributors and traders.
click here to find a list of Midazolam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Midazolam as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Midazolam API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Midazolam as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Midazolam and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Midazolam NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Midazolam suppliers with NDC on PharmaCompass.
We have 11 companies offering Midazolam
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?